{"filings":[{"id":1138318,"accession_number":"0001213900-26-070101","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-06-18T20:06:31+00:00","items":["1.01","9.01"],"status":"ready","headline":"SS Innovations enters $50M ATM equity offering with Virtu Americas","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered ATM Sales Agreement with Virtu Americas LLC to sell up to $50M of common stock.","Virtu will act as exclusive sales agent; compensation up to 3.0% of gross proceeds.","Prospectus supplement filed under existing S-3 shelf registration (File No. 333-295501).","Sales may be made through 'at the market' methods as defined in Rule 415(a)(4)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1038036,"accession_number":"0001213900-26-068479","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-06-15T10:07:49+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations files updated June 2026 investor presentation; no specific metrics disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished a June 2026 investor presentation for shareholder and investment community communications.","Presentation emphasizes surgical robotic solutions but provides no financial results, guidance, or operational updates in the available excerpt.","Ticker SSII; presentation is furnished, not filed, under Item 7.01."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":843679,"accession_number":"0001213900-26-065036","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-06-04T12:35:25+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes world's longest robotic telesurgery over 12,500 miles using SSi Mantra","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["World record: 12,500-mile (20,000 km) telesurgery from Guyana to India using SSi Mantra, performed by CEO Dr. Sudhir Srivastava.","Network latency of 290–300 ms; procedure was a Left Internal Mammary Artery (LIMA) takedown for cardiac surgery.","Total of 22 cardiac telesurgeries and 173 telesurgeries globally performed with SSi Mantra, the only system used for cardiac telesurgery.","SSi Mantra received regulatory approval from Guyana's GA-FDD in May 2026; now approved in 14 countries.","Achievement coincides with launch of Guyana's National Robotic Surgery Program and Guyana's 60th Independence anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":667916,"accession_number":"0001213900-26-061027","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-05-26T20:15:40+00:00","items":["5.02"],"status":"ready","headline":"Milan Rao steps down as Global COO and CFO of SS Innovations effective May 25, 2026; CFO search initiated","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Milan Rao will step down as Global Chief Operating Officer and Chief Financial Officer on May 25, 2026.","SS Innovations has begun a search process for a permanent CFO successor.","No interim appointment or replacement named for the CFO position."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":50643,"accession_number":"0001213900-26-055468","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-05-13T12:30:18+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations Q1 revenue $11.1M (+117% YoY); net loss narrows to $3.6M; installations up 73%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $11.1M, up 116.8% YoY from $5.1M; gross margin 48.0% vs 21.2% in Q1 2025.","Net loss $3.6M ($0.02/share) vs $5.7M ($0.03) in Q1 2025; cash $16.0M, no long-term debt.","SSi Mantra installations 26 (+73% YoY); cumulative installed base 194 across 11 countries; 9,744 cumulative surgeries.","Regulatory approvals: NMRA (Sri Lanka) and PPB (Kenya); telesurgery approvals in Indonesia and Philippines.","March 2026 private placement raised ~$18.6M gross; FDA 510(k) review expected in 2026 and CE marking pathway."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":11101366.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94612,"accession_number":"0001213900-26-053082","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes 4,500+ mile telesurgery using SSi Mantra system","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Successful remote robotic gastrojejunostomy performed May 2, 2026, from Perth, Australia to Indore, India.","Surgeon used SSi MantrAsana tele-surgeon console; procedure conducted at Royal Australian College of Surgeons congress.","Over 170 telesurgeries have been performed with the SSi Mantra system to date.","Company says telesurgery has potential to democratize access to global surgical expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94611,"accession_number":"0001213900-26-051915","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations surpasses 10,500 cumulative surgeries with SSi Mantra robotic system","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["As of April 30, 2026, cumulative surgeries with SSi Mantra exceeded 10,500, including over 500 cardiac, 170 telesurgeries, and 125 pediatric cases.","More than 2,100 physicians trained on the system, which has been used for over 170 different procedure types since commercial launch in August 2022.","Global installed base expanded to over 200 systems across 11 countries.","CEO Dr. Sudhir Srivastava cited advanced technology, ease of training, and cost advantages as drivers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94610,"accession_number":"0001213900-26-046888","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SSII unveils drone surgical robot, humanoid platform, mobile OR at SMRSC 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Unveiled SSi Vimana Aero drone system for battlefield surgery via remote control.","Showcased SSi Avtara humanoid surgical robot and SSi Operion mobile operating room.","Conference drew 1,600 in-person and 1,800 virtual attendees from 19 nations.","Performed 10 live telesurgeries and 13 live robotic surgeries using SSi Mantra.","Single-arm robotic endoscopy/ultrasound carts in early clinical validation in India."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94609,"accession_number":"0001213900-26-040714","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations to host SMRSC 2026 conference in New Delhi, April 9-11, showcasing new telesurgery and drone systems","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Conference expected to surpass last year's attendance of 1,400 in-person, 600 virtual from 17 nations.","More than 20 live telesurgeries to be performed using SSi Mantra system.","New SSi MantrAsana compact console and SSi Vimana Aero drone trauma system showcased.","Keynote guests include 'Father of Robotic Surgery' Dr. Fred Moll and other global surgeons.","MantraM bus mobile telesurgery unit on display for remote surgical care delivery."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107124,"accession_number":"0001213900-26-036006","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SSi Mantra approved in Colombia, Oman, Sri Lanka, Kenya; total approvals now 11 countries","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Regulatory approvals from INVIMA (Colombia, Nov 2025), DGPA&DC (Oman, Nov 2025), NMRA (Sri Lanka, Jan 2026), and PPB (Kenya, Jan 2026).","Cumulative installed base of SSi Mantra reached 168 systems across 10 countries as of Dec 31, 2025.","Cumulative surgeries total 7,885 including 390 cardiac and 121 pediatric; over 150 telesurgeries performed.","Company anticipates FDA 510(k) decision by mid-2026 and CE marking in 2026 for SSi Mantra."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107123,"accession_number":"0001213900-26-029907","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations’ SSi Mantra approved for telesurgeries in Indonesia and Philippines; 150+ procedures done","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SSi Mantra surgical robot receives regulatory approval for telesurgeries in Indonesia and the Philippines.","Cumulative telesurgeries surpass 150; notable feat includes 18 inter-hospital procedures in 8 hours on Feb 14, 2026.","Company to host Global Multi-Specialty Robotic Surgery Conference 2026 in New Delhi, April 9-11, with over 20 live telesurgeries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107122,"accession_number":"0001213900-26-025441","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations Q4 revenue up 79% to $14.5M; raises $18.6M in private placement","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $14.5M (+79% YoY); gross margin 43.9%; net loss $2.5M ($0.01/share).","Full year revenue $42.5M (+106% YoY); net loss $12.1M ($0.06/share) vs $19.2M loss in 2024.","SSi Mantra installations: 40 in Q4 (+82% YoY), 103 in FY2025 (+119%); cumulative base 168 across 10 countries.","Completed $18.6M private placement of 5.77M shares; insiders bought 1.3M shares at $4.00, non-affiliates at $3.00.","FDA 510(k) review for SSi Mantra expected by mid-2026; CE marking pathway ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107121,"accession_number":"0001213900-26-024938","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"SS Innovations completes $18.6M private placement; funds expansion, FDA review mid-2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raised $18.6M gross via private placement of 5,774,839 shares at $3.00-$4.01 per share.","Insiders invested $5.2M: CEO ($2.0M), Vice Chairman Moll ($2.0M), Director Adams ($1.2M).","External investors, led by Manipal Global Health Services, invested $13.4M at $3.00/share.","Proceeds for working capital, global expansion, and preparation for US/EU market entry.","FDA 510(k) review for SSi Mantra system expected mid-2026; CE marking targeted in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107120,"accession_number":"0001213900-26-003688","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations: preliminary Q4 revenue $15.0M, FY revenue $43.0M, installations up 119%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue expected ~$15.0M, up 85% YoY; Q4 Mantra installations 37, up 68% YoY.","FY2025 revenue expected ~$43.0M, up 108% YoY; FY installations 103, up 119% YoY.","Cumulative installed base of SSi Mantra reached 168 as of Dec 31, 2025, up 158% from 65.","FDA 510(k) review for SSi Mantra anticipated in H1 2026; CE marking targeted H1 2026.","Full Q4 financial results expected before end of February 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":42484747.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107119,"accession_number":"0001213900-26-002572","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"SS Innovations appoints Milan Rao as CFO and Global COO; CFO Amar resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Naveen Kumar Amar resigned Jan 2 for personal reasons; succeeded by Milan Rao as CFO and new Global COO, effective Jan 16.","Rao has 30+ years exec leadership at GE Healthcare, Wipro, Smart Energy Water; will be based in Princeton, NJ.","Compensation: monthly base $41,667; 120,000 shares vesting monthly over one year under 2016 Incentive Plan.","Rao will work closely with Chairman/CEO during transition; role aims to scale SSi Mantra robotic system."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107118,"accession_number":"0001213900-26-001594","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes five 5mm surgical instruments for pediatric, cardiac, head/neck procedures","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Five new 5mm instruments: spatula cautery, hook cautery, needle driver, bipolar forceps, grasping forceps.","Targets 1.7B children lacking surgical access; also cardiac (e.g., IMA harvesting) and head/neck procedures.","SSi Mantra installed base: 168 systems in 153 hospitals; 7,800+ procedures (400 cardiac, 120 telesurgeries).","Instruments expand robotic surgery to smaller anatomical structures; 12 systems deployed outside India."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123462,"accession_number":"0001213900-25-122031","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"SS Innovations files 8-K for CEO interview; no material news disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filing announces CEO interview with Nasdaq published Dec 16, 2025.","No financial metrics, guidance, or operational changes disclosed.","Event is a Regulation FD disclosure, not a news event."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123461,"accession_number":"0001213900-25-118977","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations submits 510(k) to FDA for SSi Mantra surgical robot; installed base reaches 138 systems","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Submitted 510(k) premarket notification to FDA on Dec 5, 2025 for SSi Mantra system covering general, urological, colorectal, gynecological, and cardiac surgeries.","EU CE marking certification expected in first half of 2026.","Cumulative installed base of 138 systems across 8 countries; 7,300+ procedures performed including 88 telesurgeries and 390 cardiac.","FDA targets 90-day review cycle for 510(k) submissions; actual approval timing may vary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123460,"accession_number":"0001213900-25-107158","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations furnishes updated November 2025 investor presentation","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company provided an updated presentation for shareholder and investor communications.","No new financial results, guidance, or specific operational milestones disclosed in the filing.","Presentation covers surgical robotic solutions; no material changes to strategy reported.","Filing is a routine Regulation FD disclosure; presentation is furnished, not filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123459,"accession_number":"0001213900-25-106854","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes first telesurgery with SSi Mantra Tele Surgeon Console","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Sudhir Srivastava performed robotic CABG remotely from New Delhi on a patient 185 miles away in Jaipur on Oct 17, 2025.","TSC is a compact chair-based console with 3D view and magnetic controls, enabling telesurgery from physician offices.","First showcased at Society of Robotic Surgery meeting in June 2024; now successfully used for a live procedure.","TSC's smaller footprint allows hospital networks to place consoles in surgical experts' offices without tying up ORs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123458,"accession_number":"0001213900-25-103137","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations Q3 revenue $12.8M (+192.5% YoY); net loss narrows to $3.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $12.8M vs $4.4M YoY; gross profit $6.2M (+166.0%) on 48.1% margin.","SSi Mantra installations 27 in Q3 (up 350% YoY); cumulative installed base 127 in seven countries.","Net loss $3.7M ($0.02/shr) vs $3.2M loss YoY; nine-month loss $9.7M vs $17.2M prior.","FDA 510(k) submission for SSi Mantra expected Q4 2025; CE marking targeted H1 2026.","Appointed Naveen Kumar Amar as CFO in September 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":27950264.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123457,"accession_number":"0001213900-25-100541","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations management to present at UBS and Stifel healthcare conferences Nov 11-12","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Sudhir Srivastava (CEO) and Dr. Vishwa Srivastava (CEO Asia Pacific) to attend.","UBS Global Healthcare Conference, Nov 11, Palm Beach Gardens, FL; one-on-one meetings all day.","Stifel 2025 Healthcare Conference, Nov 12, New York, NY; group presentation at 4:40 p.m. ET.","Webcast and replay of Stifel presentation available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123456,"accession_number":"0001213900-25-098261","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations furnishes updated October 2025 company presentation on surgical robotics","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation highlights the company's focus on building advanced, affordable surgical robotic solutions.","No specific financial or operational updates were disclosed in the limited presentation excerpt provided.","Filing is a routine Regulation FD disclosure, used for communications with shareholders and investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123455,"accession_number":"0001213900-25-095851","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes human factors validation study for SSi Mantra; plans FDA 510(k) in Q4 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed human factors validation study for SSi Mantra surgical robotic system at Johns Hopkins Hospital in September 2025.","Anticipates submitting 510(k) premarket notification to FDA in Q4 2025; potential US clearance in H1 2026 if FDA approves.","Company pivoted from De Novo request to 510(k) pathway for speed and cost advantages per FDA discussions.","SSi Mantra cumulative installed base: 125 systems across 6 countries; 119 hospitals, over 6,000 procedures performed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140135,"accession_number":"0001213900-25-091939","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-09-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SS Innovations appoints Naveen Kumar Amar CFO effective September 24, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Naveen Kumar Amar appointed CFO with a five-year employment agreement and base salary ~$163,000.","He replaces interim CFO Dr. Vishwa Srivastava, who continues as CEO – Asia Pacific.","Mr. Amar brings over 27 years of global finance leadership experience across industries and geographies.","He is a Chartered Accountant and Company Secretary in India; previously held CFO roles at SpiceXpress, Munchado, and MSD Wellcome Trust."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140134,"accession_number":"0001213900-25-087939","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes world's first pediatric pyeloplasty telesurgery with SSi Mantra","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Chandra Mohan Vaddi performed remote robotic pyeloplasty from ~1,000 miles on a 16-month-old in Hyderabad.","Over 50 telesurgeries completed across pediatric, cardiac, urology, oncology, and general surgery categories.","Company plans to develop smaller instrumentation to expand SSi Mantra's pediatric robotic surgery capabilities.","CEO states telesurgery enables reaching rural patients and democratizing advanced surgical care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140133,"accession_number":"0001213900-25-085866","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes first robotic telesurgery from MantraM mobile unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Chittawar guided a complex hysterectomy remotely from MantraM bus to HER Health in Bhopal, India.","Telesurgery used SSi Mantra system; MantraM bus aims to bring surgical care to underserved populations.","Company launched a MantraM bus tour across India in July 2025 for demonstrations at hospitals and medical colleges."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140132,"accession_number":"0001213900-25-072842","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations Q2 revenue up 122% to $10M; net loss narrows to $0.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $10.0M, up 121.8% YoY; gross margin expanded to 59.1% from 31.9%.","Net loss of $0.3M vs. $4.1M loss in Q2 2024; EPS $(0.00) per diluted share.","SSi Mantra installations totaled 23 in quarter, up 130% YoY; cumulative base 105 in 7 countries.","Cash and cash equivalents $11.4M; long-term debt $0.","Plans to submit 510(k) for SSi Mantra 3 to FDA by end of September 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":15120915.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140131,"accession_number":"0001213900-25-068204","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SS Innovations announces CFO change; interim CFO steps down, CEO Asia-Pacific named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Arvind Palaniappan stepped down as Interim CFO effective July 23, 2025.","Dr. Vishwajyoti P. Srivastava, CEO – Asia Pacific, assumes interim CFO duties.","Company is conducting a search for a permanent CFO successor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140130,"accession_number":"0001213900-25-066356","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes world's first intercontinental robotic cardiac telesurgery over 4,000 miles","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Dr. Sudhir Srivastava performed an atrial septal defect closure remotely from Strasbourg, France to Indore, India on July 19, 2025 using the SSi Mantra 3 system.","Procedure conducted without technical issues, with imperceptible latency and flawless precision.","To date, 35 telesurgeries (10 cardiac) and over 5,000 multi-specialty surgeries completed with SSi Mantra, no device-related adverse events.","SS Innovations holds CDSCO regulatory approval (India equivalent of FDA) for both tele proctoring and telesurgery.","Milestone aimed at democratizing cardiac care access for regions with limited surgical expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140129,"accession_number":"0001213900-25-063948","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations surpasses 100 installations of SSi Mantra; >5,000 procedures completed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Over 100 SSi Mantra systems installed in India and six other countries.","More than 5,000 surgeries performed, including 240 cardiac and 32 telesurgeries.","As of Dec 31, 2024: 2,759 surgeries, 151 cardiac, 9 telesurgeries.","Expects to submit De Novo application to FDA by end of July 2025 for multiple indications.","Pursuing CE marking certification for EU as soon as late 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140128,"accession_number":"0001213900-25-062539","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"World's first robotic telesurgery for weight loss completed with SSi Mantra 3","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Two One-Anastomosis Gastric Bypass (OAGB) procedures performed via telesurgery over 560 miles with zero perceptible lag.","Dr. Mohit Bhandari, President of IRCAD India, remotely operated from Gurugram, India.","Surgeries executed at Mohak Bariatric & Robotic Surgery Centre in Indore, India.","CEO Sudhir Srivastava: 'distance is no longer a barrier to advanced medical care.'"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157779,"accession_number":"0001213900-25-054503","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations' SSi Mantra 3 used for first robotic cardiac surgery in Western Hemisphere","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First robotic cardiac surgery in the Americas performed June 8, 2025, at Interhospital in Guayaquil, Ecuador.","Dr. Juan Zuniga performed robotic Atrial Septal Defect closure using the SSi Mantra 3 system.","Procedure successfully closed hole between upper heart chambers; patient recovering well."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157778,"accession_number":"0001213900-25-050789","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-06-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations International releases updated Company Presentation for June 2025","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Filed on June 3, 2025, the 8-K includes an updated Company Presentation as Exhibit 99.1.","Presentation highlights SS Innovations' surgical robotic solutions: advanced, affordable, accessible.","Company trades on Nasdaq under ticker SSII and uses presentation for shareholder communications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157777,"accession_number":"0001213900-25-049703","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations to ring Nasdaq opening bell; cites 4,000+ surgeries with SSi Mantra","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Ringing Nasdaq opening bell on June 3, 2025 in NYC; CEO Dr. Sudhir Srivastava to lead ceremony.","Celebrates April 2025 Nasdaq uplisting and milestone of over 4,000 robotic surgeries using SSi Mantra.","Over 100 types of surgeries performed without any complications, injuries, or mortalities.","On track to introduce SSi Mantra in European Union and United States; expanded from India and six other countries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157776,"accession_number":"0001213900-25-047561","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SSi Mantra robot surpasses 4,000 surgeries, zero complications; targeting CE mark late 2025, FDA H1 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SSi Mantra system used in >4,000 surgeries across >100 types with no complications, injuries, or mortalities.","Milestone includes ~215 cardiac procedures, of which 6 were telesurgery across India using SSi Mantra 3.","System cleared for market in 7 countries: India, Nepal, Ecuador, Guatemala, Philippines, Indonesia, Ukraine.","Company expects CE Mark decision as soon as late 2025 and FDA decision as soon as first half 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157775,"accession_number":"0001213900-25-047075","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SS Innovations appoints Dr. Vishwajyoti Srivastava as CEO – Asia Pacific, increases base pay to $300K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Vishwajyoti P. Srivastava, formerly President & COO Asia, appointed CEO – Asia Pacific effective May 21, 2025.","New role includes oversight of operations, marketing, regulatory affairs, and business expansion across Asia Pacific region.","Base compensation increased to $300,000 annually as part of appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157774,"accession_number":"0001213900-25-043384","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations Q1 revenue $5.1M (+40.8% YoY); net loss narrows; FDA submission planned by July 2025","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $5.1M (+40.8% YoY); gross margin 21.23% (up 121 bps); net loss $5.7M ($0.03 diluted) vs $9.8M ($0.06) in Q1 2024.","SSi Mantra installations 15 in Q1 (+66.7%), cumulative installed base 78, cumulative surgeries 3,568.","Cash $15.9M, zero long-term debt; subsequently uplisted to Nasdaq on April 25, 2025.","Plan to submit De Novo FDA application for SSi Mantra by July 2025; CE Mark possible late 2025.","Achieved world's first robotic cardiac telesurgery; gained regulatory approvals in Philippines and Ukraine."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":5120610.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157773,"accession_number":"0001213900-25-040839","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations plans FDA De Novo submission for SSi Mantra 3 in July 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Planned De Novo Classification Request to FDA in July 2025 for multispecialty indications including urology, gynecology, general surgery, thoracic and cardiac.","80 SSi Mantra systems installed in 75 hospitals since August 2022; over 3,800 surgeries performed, including 200 robotic cardiac.","SSi Mantra 3 launched June 2024; 37 systems installed with over 750 procedures (70 cardiac) and no device-related mortality or complications.","Clinical data validated by a leading third-party CRO for safety, feasibility and efficacy.","Company holds approvals in seven countries and is also pursuing European CE Mark approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157772,"accession_number":"0001213900-25-039453","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SS Innovations reiterates Q1 revenue guidance of ~$6.4M; April orders up 200% YoY to 9 systems","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 revenue expected ~$6.4M with gross margin ~45% (preliminary unaudited).","14 SSi Mantra systems installed in Q1, cumulative 78 as of March 31, 2025.","As of April 30, 2025: 80 systems installed in 75 hospitals; >3,800 surgeries performed.","April 2025 orders for SSi Mantra were 9, up 200% from 3 in April 2024.","Q1 2025 financial results expected on or about May 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":5120610.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157771,"accession_number":"0001213900-25-038698","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SS Innovations appoints Arvind Palaniappan as Interim CFO; Anup Sethi steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anup Sethi departed as CFO effective April 30, 2025; will advise during permanent CFO search.","Arvind Palaniappan named Interim CFO effective May 1, 2025, under one-year consulting agreement.","Palaniappan's fee is approx. $7,100/month under consulting deal with Trogon Consulting.","CFO transition follows SS Innovations' uplisting to Nasdaq on April 25, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157770,"accession_number":"0001213900-25-034814","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations approved for Nasdaq listing; trading begins April 25 under SSII","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common stock approved for listing on Nasdaq Capital Market; trading begins April 25, 2025 under symbol SSII.","Installed 80 SSi Mantra systems in 75 hospitals; performed 3,500+ surgeries including 195 robotic cardiac surgeries with zero device-related mortality.","Received CDSCO approval for telesurgery/tele-proctoring; performed 16 telesurgeries including world's first robotic cardiac telesurgery up to 1,200 miles.","FY2024 revenue $20.6M (+251% YoY); gross margin 40.9% (up from 12.3% in 2023).","Pursuing EU CE Mark (late 2025) and U.S. FDA approval (early 2026) for SSi Mantra system."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176148,"accession_number":"0001213900-25-025805","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SS Innovations reports ~$22M preliminary 2024 revenue, almost 4x YoY; Q1 2025 est $6.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary 2024 revenue ~$22M (unaudited), up from ~$5.5M in 2023; gross margin improved to 36.9% from 12.3%.","Q1 2025 estimated revenue ~$6.4M with ~45% gross margin; installations rose from 64 to 78 systems.","SSi Mantra systems installed at 75 hospitals; performed 3,500+ surgeries with zero device-related mortality.","Expects FDA & CE approvals by end of 2025/early 2026; also received CDSCO approval for telesurgery in India.","Appointed independent directors Tim Adams and Dr. Frederic Moll (founder of Intuitive Surgical) to board."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":5120610.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176147,"accession_number":"0001013762-25-003006","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations performs India's first 2,000-km North-to-South robotic cardiac telesurgery","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SSi Mantra 3 system enabled telesurgery from Gurugram to Bengaluru, covering >2,000 km.","Procedure on a 35-year-old patient closed an Atrial Septal Defect; lasted 2h 40min.","Low latency and real-time precision demonstrated; CDSCO-approved for telesurgery.","Led by CEO Dr. Sudhir Srivastava (Gurugram) and Dr. Arul Furtado (Bengaluru)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176146,"accession_number":"0001213900-25-023437","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations unveils India’s first Mobile Tele-Surgical Unit at SMRSC 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Unveiled SSI MantraM Mobile Tele-Surgical Unit at SMRSC 2025 in Gurugram, India, March 7-9, 2025.","Unit integrates SSi Mantra 3 Surgical Robotic System with high-speed telecom for remote surgeries.","Over 1,200 medical professionals attended the two-day conference.","SSi Mantra 3 is the only robotic system with CDSCO regulatory approval for telesurgery and tele-proctoring.","Aims to deliver robotic-assisted surgery to underserved and remote regions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176145,"accession_number":"0001213900-25-021748","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations launches SMRSC 2025, touts SSi Mantra 3 with 3,200+ surgeries and new mobile unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Conference SMRSC 2025 runs March 7-9 in Gurugram, India, featuring live robotic surgeries in five specialties.","SSi Mantra 3 system has performed over 3,200 multi-specialty surgeries globally across 70+ hospitals.","Launch of SSi Mantra Mobile Unit, a mobile surgical bus designed to expand access to advanced robotic surgery.","SSi Mantra 3 is the only robotic system worldwide with CDSCO approval for telesurgery and tele-proctoring.","Conference features notable participants including Dr. Frederic Moll and Dr. Michio Kaku."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176144,"accession_number":"0001213900-25-006206","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["3.02","8.01"],"status":"ready","headline":"CEO provides $17M in convertible note financing to SS Innovations","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Dr. Sudhir Srivastava provided $2M (Dec 2024), $5M (Jan 3, 2025), and $10M (Jan 20, 2025) in convertible notes.","Notes bear 7% annual interest, mature in one year, convertible at $1.38 per share.","Additional undetermined financing expected for capacity expansion and working capital in 2025.","Notes issued under Rule 506(b) to accredited investor (Sushruta Pvt Ltd, controlled by CEO)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176143,"accession_number":"0001213900-25-002861","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations performs world's first robotic cardiac telesurgeries with SSi Mantra 3","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Two telesurgeries completed from Gurugram to Jaipur (286 km): IMA harvesting (58 min) and beating-heart TECAB.","Latency of 35-40 ms during procedures, remotely controlled by Dr. Sudhir Srivastava.","SSi Mantra 3 is first robotic system with CDSCO approval for telesurgery and teleproctoring in India.","Procedures demonstrate potential to overcome geographical barriers for advanced cardiac care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193052,"accession_number":"0001213900-24-107884","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations completes BDO re-audit, restates FY2022-2023 financials; withdraws S-1, plans Nasdaq uplisting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BDO India completed re-audit of FY2022 and FY2023; restated financials filed in Form 10-K/A on Dec 6, 2024.","Shareholders' equity increased by $5.42M to $19.72M; working capital surplus up $3.85M to $12.96M as of Dec 31, 2023.","Total comprehensive loss for 2023 decreased by $0.16M to $21.13M; revenue unchanged at $5.88M.","Company withdrew pending Form S-1 registration statement filed Feb 14, 2024; plans to uplist to Nasdaq without offering.","Over 2,500 robotic procedures completed; systems installed in 5 countries, expansion to Indonesia."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193051,"accession_number":"0001213900-24-107156","cik":1676163,"company_name":"SS Innovations International, Inc.","ticker":"SSII","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SS Innovations receives CDSCO approval for Telesurgery, Teleproctoring via SSi Mantra","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["First and only company in India to get CDSCO regulatory approval for telesurgery and teleproctoring capabilities of its SSi Mantra surgical robotic system.","Approval enables remote surgical procedures, democratizing access to specialized care in underserved and remote areas.","CEO Dr. Sudhir Srivastava calls it a four-decade dream realized, reinforcing India as a healthcare innovation hub.","SSi Mantra is a made-in-India system integrated with advanced precision and control for improved patient outcomes.","No financial impact or guidance provided; event is a regulatory milestone."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":758498499.9095744,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-12-10T23:59:59+00:00|193051"}